Incyte (INCY) Misses Q3 EPS by 14c; Boosts FY15 Jakafi Net Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

November 3, 2015 7:06 AM EST

Incyte (NASDAQ: INCY) reported Q3 EPS of ($0.22), $0.14 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $187.7 million versus the consensus estimate of $179.3 million.

The Company has updated its full year 2015 financial guidance, as detailed below.

Previous Guidance Updated Guidance
Jakafi net product revenues $560-$575 million $580-$590 million
Contract revenue (including milestone revenues) $58 million $78 million
Research and development expenses $475-$500 million, includes non-cash stock compensation expense of $40-$45 million Unchanged
Selling, general and administrative expenses $195-$210 million, includes non-cash compensation expense of $30-$35 million $200-$210 million, includes non-cash compensation expense of $30-$35 million

For earnings history and earnings-related data on Incyte (INCY) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings